1. SH3YL1 protein as a novel biomarker for diabetic nephropathy in type 2 diabetes mellitus
- Author
-
Hye Sook Min, Soo Jin Lee, Gyu Sik Choi, Young Sun Kang, Jung Yeon Yoo, Jung Yeon Ghee, Ji Eun Lee, Sang Youb Han, Dae Ryong Cha, Kitae Kim, Ji Ae Yoo, Yun Soo Bae, Sung Hwan Moon, Sae Rom Lee, and Jin Joo Cha
- Subjects
Adult ,Male ,medicine.medical_specialty ,Endocrinology, Diabetes and Metabolism ,Medicine (miscellaneous) ,030209 endocrinology & metabolism ,Type 2 diabetes ,030204 cardiovascular system & hematology ,Cell Line ,Diabetic nephropathy ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,Diabetes mellitus ,medicine ,Albuminuria ,Animals ,Humans ,Diabetic Nephropathies ,Aged ,Retinol binding protein 4 ,Nutrition and Dietetics ,biology ,Podocytes ,business.industry ,Membrane Proteins ,Type 2 Diabetes Mellitus ,Middle Aged ,medicine.disease ,Angiotensin II ,Up-Regulation ,Mice, Inbred C57BL ,Disease Models, Animal ,Endocrinology ,Postprandial ,Diabetes Mellitus, Type 2 ,Case-Control Studies ,biology.protein ,Biomarker (medicine) ,Female ,Cardiology and Cardiovascular Medicine ,business ,Retinol-Binding Proteins, Plasma ,Biomarkers - Abstract
Background and aims Oxidative stress contributes to development of diabetic nephropathy. We implicated SH3YL1 in oxidative stress-induced inflammation and examined whether SH3YL1 could be used as a new biomarker of diabetic nephropathy. Methods and results In this study, we investigated the relationship between plasma level of SH3YL1 and diabetic nephropathy in patients with type 2 diabetes. In addition, we examined the physiological role of SH3YL1 in db/db mice and cultured podocytes. Plasma SH3YL1 concentration was significantly higher in patients with diabetes than in controls, even in normoalbuminuric patients, and was markedly increased in the macroalbuminuria group. Plasma SH3YL1 level was positively correlated with systolic blood pressure, HOMA-IR, postprandial blood glucose, plasma level of retinol binding protein 4 (RBP 4), and urinary albumin excretion (UAE) and was inversely correlated with BMI. Regression analysis showed that plasma level of RBP 4, UAE, and BMI were the only independent determinants of plasma SH3YL1 concentration. In db/db mice, plasma and renal SH3YL1 levels were significantly increased in mice with diabetes compared with control mice. In cultured podocytes, high glucose and angiotensin II stimuli markedly increased SH3YL1 synthesis. Conclusion These findings suggest that plasma level of SH3YL1 offers a promising new biomarker for diabetic nephropathy.
- Published
- 2021
- Full Text
- View/download PDF